HomeCompareMBCI vs RYLD

MBCI vs RYLD: Dividend Comparison 2026

MBCI yields 400000.00% · RYLD yields 12.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MBCI wins by $5.011119029548644e+32M in total portfolio value
10 years
MBCI
MBCI
● Live price
400000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.011119029548644e+32M
Annual income
$500,865,583,351,836,840,000,000,000,000,000,000,000.00
Full MBCI calculator →
RYLD
RYLD
● Live price
12.14%
Share price
$14.95
Annual div
$1.81
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$44.5K
Annual income
$2,587.35
Full RYLD calculator →

Portfolio growth — MBCI vs RYLD

📍 MBCI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMBCIRYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MBCI + RYLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MBCI pays
RYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MBCI
Annual income on $10K today (after 15% tax)
$34,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$425,735,745,849,061,300,000,000,000,000,000,000,000.00/yr
RYLD
Annual income on $10K today (after 15% tax)
$1,031.60/yr
After 10yr DRIP, annual income (after tax)
$2,199.25/yr
At 15% tax rate, MBCI beats the other by $425,735,745,849,061,300,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MBCI + RYLD for your $10,000?

MBCI: 50%RYLD: 50%
100% RYLD50/50100% MBCI
Portfolio after 10yr
$2.505559514774322e+32M
Annual income
$250,432,791,675,918,420,000,000,000,000,000,000,000.00/yr
Blended yield
99.95%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MBCI buys
0
RYLD buys
0
No recent congressional trades found for MBCI or RYLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMBCIRYLD
Forward yield400000.00%12.14%
Annual dividend / share$2.00$1.81
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$5.011119029548644e+32M$44.5K
Annual income after 10y$500,865,583,351,836,840,000,000,000,000,000,000,000.00$2,587.35
Total dividends collected$5.010957816668433e+32M$18.8K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: MBCI vs RYLD ($10,000, DRIP)

YearMBCI PortfolioMBCI Income/yrRYLD PortfolioRYLD Income/yrGap
1← crossover$40,010,700$40,000,000.00$11,914$1,213.65+$40.00MMBCI
2$149,615,521,729$149,572,710,280.37$14,099$1,351.30+$149615.51MMBCI
3$522,880,052,725,200$522,719,964,116,949.25$16,580$1,494.55+$522880052.71MMBCI
4$1,707,862,989,289,045,000$1,707,303,507,632,628,700.00$19,384$1,642.61+$1707862989289.03MMBCI
5$5,213,509,402,845,684,000,000$5,211,681,989,447,144,000,000.00$22,535$1,794.70+$5213509402845684.00MMBCI
6$14,874,219,058,409,543,000,000,000$14,868,640,603,348,497,000,000,000.00$26,063$1,950.00+$14874219058409543680.00MMBCI
7$39,661,196,234,050,755,000,000,000,000$39,645,280,819,658,260,000,000,000,000.00$29,995$2,107.69+$3.966119623405075e+22MMBCI
8$98,838,436,350,327,300,000,000,000,000,000$98,795,998,870,356,880,000,000,000,000,000.00$34,361$2,266.99+$9.88384363503273e+25MMBCI
9$230,205,236,474,344,900,000,000,000,000,000,000$230,099,479,347,450,050,000,000,000,000,000,000.00$39,194$2,427.12+$2.302052364743449e+29MMBCI
10$501,111,902,954,864,400,000,000,000,000,000,000,000$500,865,583,351,836,840,000,000,000,000,000,000,000.00$44,525$2,587.35+$5.011119029548644e+32MMBCI

MBCI vs RYLD: Complete Analysis 2026

MBCIStock

MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. It owns a proprietary technology for the generation of monoclonal antibodies against desired antigens, such as cancer markers. The company was formerly known as Smartec Holdings, Inc. and changed its name to MabCure Inc. in January 2008 to reflect its new business plan. MabCure Inc. was founded in 2006 and is based in White Plains, New York.

Full MBCI Calculator →

RYLDETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →
📬

Get this MBCI vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MBCI vs SCHDMBCI vs JEPIMBCI vs OMBCI vs KOMBCI vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.